Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?

被引：5

作者：

Muller, Ebba Gloersen ^{[1
,2
]}

Edwin, Trine Holt ^{[3
,4
,5
]}

Strand, Bjorn Heine ^{[4
,5
,6
]}

Stokke, Caroline ^{[1
,7
]}

Revheim, Mona Elisabeth ^{[1
,2
]}

Knapskog, Anne-Brita ^{[4
]}

机构：

[1] Oslo Univ Hosp, Dept Nucl Med, Div Radiol & Nucl Med, Oslo, Norway

[2] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway

[3] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway

[4] Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway

[5] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway

[6] Norwegian Inst Publ Hlth, Dept Chron Dis & Ageing, Oslo, Norway

[7] Univ Oslo, Dept Phys, Oslo, Norway

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2022年 / 85卷 / 01期

关键词：

Alzheimer's disease; amyloid-beta; clinical progression; Flutemetamol; PET-CT; trajectories; MILD COGNITIVE IMPAIRMENT; DIAGNOSTIC GUIDELINES; HYPOTHETICAL MODEL; NATIONAL INSTITUTE; DEMENTIA; RECOMMENDATIONS; WORKGROUPS; VALIDITY; DECLINE; SCALE;

D O I：

10.3233/JAD-215046

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Background: Patients with Alzheimer's disease (AD) show heterogeneity in clinical progression rate, and we have limited tools to predict prognosis. Amyloid burden from F-18-Flutemetamol positron emission tomography (PET), as measured by standardized uptake value ratios (SUVR), might provide prognostic information. Objective: We investigate whether F-18-Flutemetamol PET composite or regional SUVRs are associated with trajectories of clinical progression. Methods: This observational longitudinal study included 94 patients with clinical AD. PET images were semi-quantified with normalization to pons. Group-based trajectory modeling was applied to identify trajectory groups according to change in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) over time. Multinomial logistic regression models assessed the association of SUVRs with trajectory group membership. Results: Three trajectory groups were identified. In the regression models, neither composite nor regional SUVRs were associated with trajectory group membership. Conclusion: There were no associations between CDR progression and F-18-Flutemetamol PET-derived composite SUVRs or regional SUVRs in clinical AD.

引用

页码：197 / 205

页数：9

共 46 条

[11] Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis [J].

Edwin, Trine Holt ;

Strand, Bjorn Heine ;

Persson, Karin ;

Engedal, Knut ;

Selbaek, Geir ;

Knapskog, Anne-Brita .

INTERNATIONAL PSYCHOGERIATRICS, 2021, 33 (08) :779-789

[12] Communicating mild cognitive impairment diagnoses with and without amyloid imaging [J].

Grill, Joshua D. ;

Apostolova, Liana G. ;

Bullain, Szofia ;

Burns, Jeffrey M. ;

Cox, Chelsea G. ;

Dick, Malcolm ;

Hartley, Dean ;

Kawas, Claudia ;

Kremen, Sarah ;

Lingler, Jennifer ;

Lopez, Oscar L. ;

Mapstone, Mark ;

Pierce, Aimee ;

Rabinovici, Gil ;

Roberts, J. Scott ;

Sajjadi, Seyed Ahmad ;

Teng, Edmond ;

Karlawish, Jason .

ALZHEIMERS RESEARCH & THERAPY, 2017, 9

[13] High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease [J].

Gunnarsson, Malin Degerman ;

Ingelsson, Martin ;

Blennow, Kaj ;

Basun, Hans ;

Lannfelt, Lars ;

Kilander, Lena .

ALZHEIMERS RESEARCH & THERAPY, 2016, 8

[14] Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes [J].

Haaksma, Miriam L. ;

Calderon-Larranaga, Amaia ;

Rikkert, Marcel G. M. Olde ;

Melis, Rene J. F. ;

Leoutsakos, Jeannie-Marie S. .

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (08) :1057-1064

[15] Time from Symptom Debut to Dementia Assessment by the Specialist Healthcare Service in Norway [J].

Helvik, Anne-Sofie ;

Engedal, Knut ;

Benth, Jurate Saltyte ;

Selbaek, Geir .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2018, 8 (01) :117-127

[16] A NEW CLINICAL-SCALE FOR THE STAGING OF DEMENTIA [J].

HUGHES, CP ;

BERG, L ;

DANZIGER, WL ;

COBEN, LA ;

MARTIN, RL .

BRITISH JOURNAL OF PSYCHIATRY, 1982, 140 (JUN) :566-572

[17] Accelerating rates of cognitive decline and imaging markers associated with -amyloid pathology [J].

Insel, Philip S. ;

Mattsson, Niklas ;

Mackin, R. Scott ;

Scholl, Michael ;

Nosheny, Rachel L. ;

Tosun, Duygu ;

Donohue, Michael C. ;

Aisen, Paul S. ;

Jagust, William J. ;

Weiner, Michael W. .

NEUROLOGY, 2016, 86 (20) :1887-1896

[18] NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease [J].

Jack, Clifford R., Jr. ;

Bennett, David A. ;

Blennow, Kaj ;

Carrillo, Maria C. ;

Dunn, Billy ;

Haeberlein, Samantha Budd ;

Holtzman, David M. ;

Jagust, William ;

Jessen, Frank ;

Karlawish, Jason ;

Liu, Enchi ;

Luis Molinuevo, Jose ;

Montine, Thomas ;

Phelps, Creighton ;

Rankin, Katherine P. ;

Rowe, Christopher C. ;

Scheltens, Philip ;

Siemers, Eric ;

Snyder, Heather M. ;

Sperling, Reisa ;

Elliott, Cerise ;

Masliah, Eliezer ;

Ryan, Laurie ;

Silverberg, Nina .

ALZHEIMERS & DEMENTIA, 2018, 14 (04) :535-562

[19] Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers [J].

Jack, Clifford R., Jr. ;

Knopman, David S. ;

Jagust, William J. ;

Petersen, Ronald C. ;

Weiner, Michael W. ;

Aisen, Paul S. ;

Shaw, Leslie M. ;

Vemuri, Prashanthi ;

Wiste, Heather J. ;

Weigand, Stephen D. ;

Lesnick, Timothy G. ;

Pankratz, Vernon S. ;

Donohue, Michael C. ;

Trojanowski, John Q. .

LANCET NEUROLOGY, 2013, 12 (02) :207-216

[20] Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade [J].

Jack, Clifford R., Jr. ;

Knopman, David S. ;

Jagust, William J. ;

Shaw, Leslie M. ;

Aisen, Paul S. ;

Weiner, Michael W. ;

Petersen, Ronald C. ;

Trojanowski, John Q. .

LANCET NEUROLOGY, 2010, 9 (01) :119-128

← 1 2 3 4 5 →